Lei, Y
Kansy, B A
Li, J
Cong, L
Liu, Y
Trivedi, S
Wen, H
Ting, J P-Y
Ouyang, H
Ferris, R L
Article History
Received: 19 June 2015
Revised: 7 October 2015
Accepted: 11 December 2015
First Online: 15 February 2016
Competing interests
: Dr Ferris‘ work is supported, in part, by Bristol-Myers Squibb, AZ/Medimmune. He serves on the Advisory Boards for Cetuximab (Bristol-Myers Squibb and Lilly) and Panitumumab (Amgen).